{"id":18368,"date":"2021-06-22T12:15:26","date_gmt":"2021-06-22T16:15:26","guid":{"rendered":"https:\/\/medicarereport.org\/?p=18368"},"modified":"2021-06-22T12:15:26","modified_gmt":"2021-06-22T16:15:26","slug":"drug-resistant-bacteria-pose-a-growing-threat-can-new-antibiotics-be-developed-fast-enough-to-combat-them","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=18368","title":{"rendered":"Drug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?"},"content":{"rendered":"<p>(By\u00a0Ed Silverman for ST<em>A<\/em>T)<\/p>\n<p>In 2016, a landmark report was issued on the global problem of antimicrobial resistance. The paper, commissioned by the U.K. government and the Wellcome Trust, sought to quickly grab the attention of policymakers \u2014 by tapping a former high-profile Goldman Sachs economist named Jim O\u2019Neill to lead the effort. He issued a particularly dire warning of what was to come if the issue was ignored.\u00a0 Continue reading the article <a href=\"https:\/\/www.statnews.com\/2021\/06\/22\/antibiotic-development-pipeline-resistance\/\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Ed Silverman for STAT) In 2016, a landmark report was issued on the global problem of antimicrobial resistance. The paper,<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,15],"tags":[],"class_list":["post-18368","post","type-post","status-publish","format-standard","hentry","category-medical-technology","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18368","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18368"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18368\/revisions"}],"predecessor-version":[{"id":18369,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18368\/revisions\/18369"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18368"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18368"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18368"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}